Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Chioncel, Ovidiu, Lainscak, Mitja, Seferovic, Petar M., Anker, Stefan D., Crespo-Leiro, Maria G., Harjola, Veli-Pekka, Parissis, John, Laroche, Cecile +10 more·2017·European Journal of Heart Failure
DOI 10.1002/ejhf.813

Cited by (930)

Items 201–300 of 930

  1. Association of the classification and severity of heart failure with the incidence of contrast-induced acute kidney injury
    Tian Xu, Maoning Lin, Xiaohua Shen, Min Wang, Wenjuan Zhang, Liding Zhao, Duanbin Li, Yi Luan, Wenbin Zhang · 2021 · Scientific Reports
  2. A Novel Paradigm Based on ST2 and Its Contribution towards a Multimarker Approach in the Diagnosis and Prognosis of Heart Failure: A Prospective Study during the Pandemic Storm
    Radu-Ştefan Miftode, Daniela Constantinescu, Corina Maria Cianga, Antoniu Octavian Petriş, Amalia Stefana Țimpău, Adrian Silviu Crişan, Irina Iuliana Costache, Ovidiu Mitu, Dana-Teodora Anton-Păduraru, Ionela-Larisa Miftode et al. · 2021 · Life
  3. Diagnosis and Management of Heart Failure
    Inna P. Gladysheva, Ryan D. Sullivan · 2022 · MDPI eBooks
  4. Heart Failure with Mid-Range Ejection Fraction: A Transition Phenotype?
    Antoni Bayés‐Genís, Julio E. Núñez, Josep Lupón · 2017 · European Journal of Heart Failure
  5. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta‐analysis
    Garen Kroshian, Jacob Joseph, Scott Kinlay, Adelqui Peralta, Peter S. Hoffmeister, Jagmeet P. Singh, Matthew Fomonyuy Yuyun · 2024 · Journal of Cardiovascular Electrophysiology
  6. Differences in medical treatment and clinical characteristics between men and women with heart failure – a single-centre multivariable analysis
    Helena Norberg, Veronica Pranic, Ellinor Bergdahl, Krister Lindmark · 2020 · European Journal of Clinical Pharmacology
  7. Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular Mortality
    Giosafat Spitaleri, Elisabet Zamora, Germán Cediel, Pau Codina, Evelyn Santiago‐Vacas, Mar Domingo, Josep Lupón, Javier Santesmases, Crisanto Díez, María Isabel Troya et al. · 2022 · Journal of Clinical Medicine
  8. Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction
    Davide Stolfo, Lars H. Lund, Gianfranco Sinagra, Felix Lindberg, Ulf Dahlström, Giuseppe M.C. Rosano, Gianluigi Savarese · 2023 · European Heart Journal - Cardiovascular Pharmacotherapy
  9. Prognostic role of mitral regurgitation in patients with advanced heart failure
    Matteo Pagnesi, Filippo Calì, Mauro Chiarito, Davide Stolfo, Luca Baldetti, Carlo Lombardi, Daniela Tomasoni, Ferdinando Loiacono, Marta Maccallini, Alessandro Villaschi et al. · 2023 · European Journal of Internal Medicine
  10. Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure
    Matteo Pagnesi, Mauro Riccardi, Mauro Chiarito, Davide Stolfo, Luca Baldetti, Carlo Lombardi, Giada Colombo, Riccardo Maria Inciardi, Daniela Tomasoni, Ferdinando Loiacono et al. · 2024 · Journal of Cardiovascular Medicine
  11. Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction: The Interplay of Valve, Ventricle, and Atrium
    Sebastiaan Dhont, Gitte P H van den Acker, Tim van Loon, Frederik Hendrik Verbrugge, Jan Verwerft, Sébastien Deferm, Timothy W. Churchill, Wilfried Müllens, Joost Lumens, Philippe B. Bertrand · 2024 · European Journal of Heart Failure
  12. Left Ventricular Ejection Fraction in Heart Failure: A Clinician's Perspective About a Dynamic and Imperfect Parameter, Though Still Convenient and a Cornerstone for Patient Classification and Management
    Josep Lupón, Antoni Bayés‐Genís · 2017 · European Journal of Heart Failure
  13. Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry
    Fernando de Frutos, Sònia Mirabet, Luis Ortega‐Paz, Irene Buera, Sara Darnés, Núria Farré, Bernardo Perez-Villa, Raquel Adeliño, Ramón Bascompte Claret, Jordi Pérez‐Rodon et al. · 2020 · ESC Heart Failure
  14. Long-Term Outcomes of Adults With Heart Failure by Left Ventricular Systolic Function Status
    Harshith Reddy Avula, Thomas Kiichi Leong, Keane K. Lee, Sue Hee Sung, Alan S. Go · 2018 · The American Journal of Cardiology
  15. Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis
    Checa, Caterina, Canelo-Aybar, Carlos, Suclupe, Stefanie, Ginesta-López, David, Berenguera, Anna, Castells, Xavier, Brotons, Carlos, Posso, Margarita · 2022 · International Journal of Environmental Research and Public Health
  16. Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study
    Jiangyue Tian, Mei Dong, Xiaoqian Sun, Xiaoning Jia, Guihua Zhang, Yanling Zhang, Zongwei Lin, Jie Xiao, Xinyu Zhang, Huixia Lu · 2024 · International Journal of Cardiology
  17. Etiology of Heart Failure Across the Ejection Fraction Spectrum and Association With Prognosis
    Kristian Kozman, Giulia Ferrannini, Lina Benson, Ulf Dahlström, Camilla Hage, Gianluigi Savarese, Bahira Shahim, Lars H Lund · 2025 · JACC Heart Failure
  18. Cost-Effectiveness of a Cardiac Contractility Modulation Device in Heart Failure With Normal QRS Duration
    Klaus Karl Witte, Gerd P Hasenfuss, Axel Kloppe, Daniel Burkhoff, Michelle Green, Joe W. E. Moss, Alison J. Peel, Stuart Mealing, Isabelle Durand‐Zaleski, Martín Cowie · 2019 · ESC Heart Failure
  19. Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes
    Alberto Palazzuoli, Matteo Beltrami · 2021 · Frontiers in Cardiovascular Medicine
  20. Influential Factors in Remote Monitoring of Heart Failure Patients: A Review of the Literature and Direction for Future Research
    Sashini Senarath, Geoff Roy Fernie, Atena Roshan Fekr · 2021 · Sensors
  21. Different heart failure phenotypes of valvular heart disease: the role of mitochondrial dysfunction
    Shenghui Zhang, Cheng Liu, Yingyuan Zhang, Zongjian Wu, Kaiwei Feng, Yanxian Lai, Jingxian Pei, Tianwang Guan · 2023 · Frontiers in Cardiovascular Medicine
  22. Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry Science
    Anubha Agarwal, Jasper Tromp, Wael A. Almahmeed, Christiane E. Angermann, Chanchal Chandramouli, Hyun‐Jai Cho, Dong‐Ju Choi, Albertino Antonio Moura Damasceno, Gerasimos S Filippatos, Gregg C. Fonarow et al. · 2024 · Circulation Heart Failure
  23. CMR-based cardiac phenotyping in different forms of heart failure
    Torben Lange, Sören Jan Backhaus, Alexander Schulz, Djawid Hashemi, Ruben Evertz, Johannes Tammo Kowallick, Gerd P Hasenfuss, Sebastian Kelle, Andreas Schuster · 2024 · The International Journal of Cardiovascular Imaging
  24. Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF?
    Toru Kondo, Alasdair David Henderson, Kieran F. Docherty, Pardeep S. Jhund, Muthiah Vaduganathan, Scott David Solomon, John J.V. McMurray · 2024 · Journal of the American College of Cardiology
  25. Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?
    Jessica Webb, Jane Draper, Lauren Fovargue, Benjamin Sieniewicz, Justin Gould, Simon Claridge, Carys Barton, S. Smith, Kristin Tøndel, Ronak Rajani et al. · 2018 · IJC Heart & Vasculature
  26. Cardiac cachexia: the mandate to increase clinician awareness
    Alessia Lena, Nicole Ebner, Andrew J.S. Coats, Markus S. Anker · 2019 · Current Opinion in Supportive and Palliative Care
  27. Early Experience of Sacubitril–Valsartan in Heart Failure with Reduced Ejection Fraction in Real-world Clinical Setting
    Charlotte Nordberg Backelin, Michael L.X. Fu, Charlotta E. A. Ljungman · 2020 · ESC Heart Failure
  28. Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF
    for the CHECK-HF investigators, Gerard C.M. Linssen, Jesse F. Veenis, Alexandra Kleberger, Marcel J. W. Grosfeld, Eric P. Viergever, Bas M. van Dalen, Wendy Bedijn, Jorina Langerveld, Hans‐Peter Brunner‐La Rocca et al. · 2020 · Clinical Research in Cardiology
  29. Clinical Relevance of the LVEDD and LVESD Trajectories in HF Patients With LVEF < 35%
    Yu-Chen Chen, Shi-Chue Hsing, Yuan‐Ping Chao, Yung‐Wen Cheng, Chin‐Sheng Lin, Chin S. Lin, Wen‐Hui Fang · 2022 · Frontiers in Medicine
  30. Substance and Substrate
    Biykem Bozkurt, Justin Adrian Ezekowitz · 2020 · Circulation
  31. Outcomes of heart failure with reduced, mildly reduced, or preserved ejection fraction: the ESC HF III registry
    Lars H. Lund, Aldo Pietro Maggioni, Maria Generosa Crespo-Leiro, Cécile Laroche, Israel Gotsman, Belma Pojskić, Eleonora Vataman, Lucica Grigorică, Hamayak S. Sisakian, Duška Glavaš et al. · 2025 · European Heart Journal
  32. Altered Heart Rate Turbulence and Variability Parameters Predict 1-Year Mortality in Heart Failure with Preserved Ejection Fraction
    Juš Kšela, Lea Rupert, Anže Djordjević, Miha Antonič, Viktor Avbelj, Borut Jug · 2022 · Journal of Cardiovascular Development and Disease
  33. Aetiology of Chronic Heart Failure in Patients from a Super-Aged Society: The KUNIUMI Registry Chronic Cohort
    Wataru Fujimoto, Ryuji Toh, Misa Takegami, Junichi Imanishi, Tomoyo Hamana, Susumu Odajima, Makoto Takemoto, Koji Kuroda, Yutaka Hatani, Soichiro Yamashita et al. · 2022 · ESC Heart Failure
  34. Survival rate and predictors of 36-month mortality in patients with heart failure in Sub Saharan Africa: insights from the Douala Heart Failure Registry (Do-HF)
    Anastase Dzudié, Blaise Forgwa Barche, Clovis Nkoké, Vitale Gloria Ngatchuesi, Marie Solange Ndom, Sidick Aboubakar Mouliom, Jules Ndjebet, Ariane Nouko, Raissa Fogue, Serah M. Abang et al. · 2022 · Cardiovascular Diagnosis and Therapy
  35. Prognostic Relevance of Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Reduced Ejection Fraction
    Surenjav Chimed, Jan Stassen, Xavier Galloo, Maria Chiara Meucci, Juhani M. Knuuti, Victoria Delgado, Pieter van der Bijl, Nina Ajmone Marsan, Jeroen Joost Bax · 2023 · The American Journal of Cardiology
  36. A Systematic Review of the Effect of Vericiguat on Patients with Heart Failure
    Urjosee Sahana, Markus Wehland, Ulf Simonsen, Herbert Schulz, Daniela G. Grimm · 2023 · International Journal of Molecular Sciences
  37. Application of an Echocardiographic Index to Characterize Right Ventricular–Pulmonary Arterial Coupling in Heart Failure
    Xin Chen, Peige Zhang, Jie Lou, Ruohan Zhao, Siyi Zhang, Mingxing Xie, Qing Lv · 2024 · ESC Heart Failure
  38. Heart Failure With Midrange Ejection Fraction in Patients Admitted for Acute Decompensation: A Report from the Japanese Multicenter Registry
    Makoto Takei, Shun Kohsaka, Yasuyuki Shiraishi, Ayumi Goda, Yuji Nagatomo, Atsushi Mizuno, Yasumori Suzino, Takashi Kohno, Keiichi Fukuda, Tsutomu Yoshikawa · 2019 · Journal of Cardiac Failure
  39. Periodic repolarization dynamics as predictor of risk for sudden cardiac death in chronic heart failure patients
    Saúl Palacios, Iwona Cygankiewicz, Antoni Bayés de Luna, Esther Pueyo, Juan Pablo Martí­nez · 2021 · Scientific Reports
  40. Heat shock protein 27 acts as a predictor of prognosis in chronic heart failure patients
    Denise Traxler, Mitja Lainščak, Elisabeth Simader, Hendrik Jan Ankersmit, Borut Jug · 2017 · Clinica Chimica Acta
  41. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China
    Si‐qi Lyu, Litian Yu, Huiqiong Tan, Shaoshuai Liu, Xiaoning Liu, Xiao Guo, Jun Zhu · 2019 · BMC Cardiovascular Disorders
  42. Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions
    Marco Metra, Daniela Tomasoni, Marianna Adamo, Stefan D. Anker, Antoni Bayés‐Genís, Ralph Stephan von Bardeleben, Michael Böhm, Erwan Donal, Gerasimos S Filippatos, Francesco Maisano et al. · 2025 · Circulation
  43. Association of body mass index and prognosis in patients with HFpEF: A dose-response meta-analysis
    Siyuan Li, Yuxiang Zheng, Yuwen Huang, Wenfeng He, Xiao Liu, Wengen Zhu · 2022 · International Journal of Cardiology
  44. From mid-range to mildly reduced ejection fraction heart failure: A call to treat
    Davide Stolfo, Enrico Fabris, Lars H. Lund, Gianluigi Savarese, Gianfranco Sinagra · 2022 · European Journal of Internal Medicine
  45. Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction
    Jonas Faxén, Lina Benson, Ängla Mantel, Gianluigi Savarese, Camilla Hage, Ulf Dahlström, Johan Askling, Lars H. Lund, Daniel C. Andersson · 2023 · American Heart Journal
  46. Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction
    Tobias Schupp, Thomas Bertsch, Marielen Reinhardt, Noah Abel, Alexander Schmitt, Felix Lau, Mohammad Abumayyaleh, Muharrem Akin, Christel Weiß, Kathrin Weidner et al. · 2024 · European Journal of Preventive Cardiology
  47. Prevalence and Prognosis of Aortic Valve Diseases in Patients Hospitalized with Heart Failure with Mildly Reduced Ejection Fraction
    Tobias Schupp, Noah Abel, Moritz Schmidberger, Mila Kathrin Höpfner, Alexander Schmitt, Marielen Reinhardt, Jan Forner, Felix Lau, Muharrem Akin, Jonas Rusnak et al. · 2024 · European Journal of Heart Failure
  48. Is Mild Asymptomatic Left Ventricular Systolic Dysfunction Always Predictive of Adverse Events in High-Risk Populations? Insights from the David-Berg Study
    Mauro Gori, Margaret M. Redfield, Alice Calabrese, Paolo Angelo Canova, Giovanni Cioffi, Renata De Maria, Aurelia Grosu, Alessandra Fontana, Attilio Iacovoni, Paola Ferrari et al. · 2018 · European Journal of Heart Failure
  49. Rationale and Design of the CardioMEMS Post-Market Multinational Clinical Study: COAST
    Martín Cowie, Pascal de Groote, Scott C. McKenzie, Marie‐Elena Brett, Philip B. Adamson · 2020 · ESC Heart Failure
  50. Implementation of Guideline-Recommended Therapies for Patients With Heart Failure and Reduced Ejection Fraction: A Regional Arab Middle East Experience
    Mohammad Zubaid, Wafa A Rashed, Mustafa Ridha, Nooshin Bazargani, Adel Khalifa Hamad, Rashed Al Banna, Nidal Asaad, Kadhim Sulaiman, Mohammad Aljarallah, Arif Al Mulla et al. · 2020 · Angiology
  51. Acute heart failure in elderly patients: a review of invasive and non-invasive management.
    Gregorio Tersalvi, Alessio Gasperetti, Marco Schiavone, Jeroen Dauw, Cecilia Gobbi, Marialessia Denora, Joël Krüll, Giacomo Maria Cioffi, Gianfranco Mitacchione, Giovanni B. Forleo · 2021 · PubMed Central
  52. The interplay between heart failure and chronic kidney disease
    Anuradha Lala, Adeera Levin, Kamlesh K. Khunti · 2025 · Diabetes Obesity and Metabolism
  53. Chronic Kidney Disease and Heart Failure–Everyday Diagnostic Challenges
    Anna Adamska-Wełnicka, Marcin Tomasz Wełnicki, Artur Mamcarz, Ryszard Gellert · 2021 · Diagnostics
  54. Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction
    Alberico Del Torto, Andrea Igoren Guaricci, Francesca Pomarico, Marco Guglielmo, Laura Fusini, Francesco Monitillo, Daniela Santoro, Monica Vannini, Alexia Rossi, Giuseppe Muscogiuri et al. · 2022 · Frontiers in Cardiovascular Medicine
  55. Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism
    Xiaoxiao Xing, Jianbo Guo, Juefei Mo, Huashan Li, Hui Zhang, Baoyi Shao, Yifan Wang, Hai-Di Li, Jianan Wang, Cheuk Lung Leung et al. · 2023 · Frontiers in Cardiovascular Medicine
  56. Syndecan-1: From a Promising Novel Cardiac Biomarker to a Surrogate Early Predictor of Kidney and Liver Injury in Patients with Acute Heart Failure
    Radu-Ştefan Miftode, Irina Iuliana Costache, Daniela Constantinescu, Ovidiu Mitu, Amalia Stefana Țimpău, Monica Hăncianu, Daniela-Anicuta Leca, Ionela-Larisa Miftode, Alexandru Raul Jigoranu, Alexandru Florinel Oancea et al. · 2023 · Life
  57. Left bundle branch area pacing in mildly reduced heart failure: A systematic literature review and meta‐analysis
    Ga‐In Yu, Tae‐Hoon Kim, Yun‐Ho Cho, JAESEOK BAE, Jong‐Hwa Ahn, Jeong Yoon Jang, Yong Whi Park, Choong Hwan Kwak · 2023 · Clinical Cardiology
  58. The effect of kidney function on guideline‐directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction
    Fanni Bánfi‐Bacsárdi, Dávid Pilecky, Máté Vámos, Zsuzsanna Majoros, Gábor Márton Török, Tünde Borsányi, Miklós Dékány, Balázs Solymossi, Peter Gabor Andreka, Gábor Zoltán Duray et al. · 2024 · Clinical Cardiology
  59. Left Atrial Roof Enlargement Is a Distinct Feature of Heart Failure With Preserved Ejection Fraction
    Sören Jan Backhaus, Anastasia Nasopoulou, Torben Lange, Alexander Schulz, Ruben Evertz, Johannes Tammo Kowallick, Gerd P Hasenfuss, Pablo Lamata, Andreas Schuster · 2024 · Circulation Cardiovascular Imaging
  60. Proteomic pathways across the ejection fraction spectrum in patients with heart failure and diabetes mellitus: an EXSCEL trial substudy
    Anthony E. Peters, Maggie Nguyen, Jennifer B. Green, Ewan R. Pearson, John B. Buse, Harald Sourij, Adrian F. Hernandez, Naveed A. Sattar, Rury R. Holman, Robert John Mentz et al. · 2025 · Scientific Reports
  61. The impact of gender in cardiovascular medicine: Lessons from the gender/sex-issue in heart failure
    Alberto Maria Marra, Andrea Salzano, Michele Arcopinto, Lucrezia Piccioli, Valeria Raparelli · 2018 · Monaldi Archives for Chest Disease
  62. Ethnic differences in acute heart failure outcomes in Ontario
    Louise Y. Sun, Antoine Kimmoun, Koji Takagi, Peter P. Liu, Anan Bader Eddeen, Alexandre Mebazaa · 2019 · International Journal of Cardiology
  63. The Potential of Oxygenation-Sensitive CMR in Heart Failure
    Elizabeth L. Hillier, Matthias G. Friedrich · 2021 · Current Heart Failure Reports
  64. Benefits and adverse effects of sacubitril/valsartan in patients with chronic heart failure: A systematic review and meta‐analysis
    Élodie Charuel, Thibault Ménini, Sabrina Bedhomme, Bruno Pereira, Nathalie Piñol‐Domenech, Suzy Bouchant, Rémy Boussageon, Sylvaine Bœuf-Gibot, Hélène Vaillant-Roussel · 2021 · Pharmacology Research & Perspectives
  65. The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction
    Anita Pintér, A Behon, Boglárka Veres, Eperke Dóra Merkel, Walter Richárd Schwertner, Luca Katalin Kuthi, Richard Masszi, Bálint Károly Lakatos, Attila D Kovács, David J Becker et al. · 2022 · Diagnostics
  66. Incident Heart Failure With Mildly Reduced Ejection Fraction: Frequency, Characteristics, and Outcomes
    Vinayak Kumar, Margaret M. Redfield, Amy E. Glasgow, Veronique Lee Roger, Susan A. Weston, Alanna M. Chamberlain, Shannon M. Dunlay · 2022 · Journal of Cardiac Failure
  67. New Biomarkers in the Prognostic Assessment of Acute Heart Failure with Reduced Ejection Fraction: Beyond Natriuretic Peptides
    Marcelino Cortés, Jairo Lumpuy‐Castillo, Camila Sofía García-Talavera, María Belén Arroyo Rivera, Lara de Miguel García, Antonio José Bollas Becerra, José María Romero-Otero, José Antonio Esteban Chapel, Mikel Taibo Urquía, Ana María Pello et al. · 2025 · International Journal of Molecular Sciences
  68. Patterns of comorbidities differentially impact on in-hospital outcomes in heart failure patients
    Veronica Murru, Elena Belfiori, Alessandro Sestu, Andrea Casanova, Carla Serra, Angelo Scuteri · 2025 · BMC Geriatrics
  69. Persistent effect of nurse-led education on self-care behavior and disease knowledge in heart failure patients
    Astrid Huesken, Rainer Hoffmann, Sofien Ayed · 2021 · International Journal of Nursing Sciences
  70. Predictive biomarkers for the early detection and management of heart failure
    Vignesh Mariappan, Rajesh Srinivasan, Ravindran Pratheesh, Muraliswar Rao Jujjuvarapu, Agieshkumar Balakrishna Pillai · 2023 · Heart Failure Reviews
  71. Heart failure with preserved ejection fraction: The role of inflammation
    Hongyi Liu, Ruth Magaye, David M. Kaye, Bing Hui Wang · 2024 · European Journal of Pharmacology
  72. What is Heart Failure with Mid-range Ejection Fraction? A New Subgroup of Patients with Heart Failure
    Sunil Kumar Nadar, Osama Tariq · 2018 · Cardiac failure review
  73. Dilated Cardiomyopathy With Mid‐Range Ejection Fraction at Diagnosis: Characterization and Natural History
    Piero Gentile, Marco Merlo, Antonio Nicola Cannata, Marco Gobbo, Jessica Artico, Davide Stolfo, Marta Gigli, Federica Ramani, Giulia Barbati, Bruno Pinamonti et al. · 2019 · Journal of the American Heart Association
  74. French annual national observational study of 2015 outpatient and inpatient healthcare utilization by approximately half a million patients with previous heart failure diagnosis
    Sarah F. Feldman, Thomas Lesuffleur, Valérie Olié, Christelle Gastaldi‐Ménager, Yves Juillière, Philippe Tuppin · 2020 · Archives of cardiovascular diseases
  75. Prognostic Significance of Lung and Cava Vein Ultrasound in Elderly Patients Admitted for Acute Heart Failure: PROFUND-IC Registry Analysis
    Sara Pérez-Herrero, Noël Lorenzo-Villalba, Elena Urbano, Beatriz Sánchez-Sauce, Fernando Aguilar-Rodríguez, Máximo Bernabeu‐Wittel, Rocío García-Alonso, Llanos Soler Rangel, Francisco Trapiello-Valbuena, Alejandra Garcia-García et al. · 2022 · Journal of Clinical Medicine
  76. Cost analysis of chronic heart failure management in Malaysia: A multi-centred retrospective study
    Siew Chin Ong, Joo Zheng Low, WY Yew, Chia How Yen, Muhamad Ali SK Abdul Kader, Houng Bang Liew, Abdul Kahar Abdul Ghapar · 2022 · Frontiers in Cardiovascular Medicine
  77. Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction
    Mauro Riccardi, Daniela Tomasoni, Enrico Vizzardi, Marco Metra, Marianna Adamo · 2022 · Heart Failure Reviews
  78. Left ventricular ejection fraction for risk stratification in chronic systolic heart failure
    Alberto Aimo, James L. Januzzi, Giuseppe Vergaro, Christina Petersen, Emilio M. Pasanisi, Sabrina Molinaro, Claudio Passino, Michele Emdin · 2018 · International Journal of Cardiology
  79. Heart Failure with Mid-range Ejection Fraction: Lessons from CHARM
    Lars H. Lund · 2018 · Cardiac failure review
  80. What’s new in heart failure therapy 2018?†
    Julian Georg Westphal, Tarek Bekfani, Paul Christian Schulze · 2018 · Interactive Cardiovascular and Thoracic Surgery
  81. Patient-Reported Outcomes in Heart Failure with Preserved vs. Reduced Ejection Fraction: Focus on Physical Independence
    Weiting Huang, Tiew‐Hwa Katherine Teng, Wan Ting Tay, Mark Richards, Umesh T. Kadam, Claire Alexandra Lawson, Wataru Shimizu, Seet Yoong Loh, Inder S. Anand, Carolyn S.P. Lam · 2020 · ESC Heart Failure
  82. From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure
    Evelina Charidemou, Kyriacos N. Felekkis, Christos P. Papaneophytou · 2025 · Biomolecules
  83. Clinical Characteristics and Outcomes of Black African Heart Failure Patients with Preserved, Mid-Range, and Reduced Ejection Fraction: A Post Hoc Analysis of the THESUS-HF Registry
    Anastase Dzudié, Martin Hongieh Abanda, Clovis Nkoké, Blaise Forgwa Barche, Albertino Antonio Moura Damasceno, Christopher Edwards, Beth A. Davison, Gad Cotter, Karen S Sliwa, THEUS-HF investigators · 2020 · ESC Heart Failure
  84. Clinical characteristics and mortality of patients with heart failure in Southern Sweden from 2013 to 2019: a population-based cohort study
    Jason Davidge, Awais Ashfaq, Kristina Malene Ødegaard, Mattias P. O. Olsson, Madlaina Costa‐Scharplatz, Björn Agvall · 2022 · BMJ Open
  85. Short-term mechanical support with the Impella 5.x for mitral valve surgery in advanced heart failure—protected cardiac surgery
    Anja Oßwald, Sharaf-Eldin Shehada, Alina Zubarevich, Markus Kamler, Matthias Thielmann, Wiebke Sommer, Alexander Weymann, Arjang Ruhparwar, Mohamed El Gabry, Bastian Schmack · 2023 · Frontiers in Cardiovascular Medicine
  86. Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target
    Ana Teresa Timóteo, Francisco Barbas de Albuquerque, Bárbara Lacerda Teixeira · 2024 · International Journal of Cardiology
  87. Medical Treatments in Patients With Ambulatory Heart Failure: First Data From the BRING-UP-3 Heart Failure Study
    Fabrizio Giovanni Oliva, Francesco Orso, Furio Colivicchi, Manlio Cipriani, Andrea Di Lenarda, Domenico Gabrielli, Mauro Gori, Marco Gorini, Massimo Iacoviello, Donata Lucci et al. · 2025 · Journal of Cardiac Failure
  88. Beta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study
    Fernando Montenegro Sá, Rita Ribeiro Carvalho, Catarina Ruivo, Luís Graça Santos, Alexandre Antunes, Francisco Soares, Adriana Belo, João Morais, on behalf of the Portuguese Registry of Acute Coronary Syndrome Investigators · 2019 · European Heart Journal Acute Cardiovascular Care
  89. Non-Insulin Antihyperglycaemic Drugs and Heart Failure: An Overview of Current Evidence from Randomized Controlled Trials
    Gianluigi Savarese, Benedikt Schrage, Francesco Cosentino, Lars H. Lund, Giuseppe M.C. Rosano, Petar M Seferovic, Javed Butler · 2020 · ESC Heart Failure
  90. Differential Effect of the Morning Blood Pressure Surge on Prognoses Between Heart Failure With Reduced and Preserved Ejection Fractions
    Takahiro Komori, Satoshi Hoshide, Kazuomi Kario · 2021 · Circulation Journal
  91. Associations between calcium channel blocker therapy and mortality in heart failure with preserved ejection fraction
    Xinyi Wang, Jianqing Ju, Zhuo Chen, Qian Lin, Zihao Zhang, Qiuyi Li, Jie Zhang, Hao Xu, Keji Chen · 2022 · European Journal of Preventive Cardiology
  92. Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry
    Alfredo De Giorgi, Alberto Maria Marra, Massimo Iacoviello, Vincenzo Triggiani, Giuseppe Rengo, Francesco Cacciatore, Ciro Maiello, Giuseppe Limongelli, Daniele Masarone, Francesco Perticone et al. · 2022 · Internal and Emergency Medicine
  93. Efficacy of SGLT2-inhibitors across different definitions of heart failure with preserved ejection fraction
    Vincenzo De Marzo, Gianluigi Savarese, Italo Porto, Marco Metra, Pietro Ameri · 2023 · Journal of Cardiovascular Medicine
  94. Potential Advantages of Torsemide in Patients with Heart Failure: More than Just a ‘Water Pill’?
    Stephen John Greene, Robert John Mentz · 2017 · European Journal of Heart Failure
  95. The Optimization of Guideline-Directed Medical Therapy during Hospitalization among Patients with Heart Failure with Reduced Ejection Fraction in Daily Clinical Practice
    Fanni Bánfi‐Bacsárdi, Balázs Muk, Dávid Pilecky, Gábor Zoltán Duray, Róbert Gábor Kiss, Noémi Nyolczas · 2022 · Cardiology
  96. Cardiac Amyloidosis and Valvular Heart Disease
    Franz Duca, Christina Kronberger, Robin Willixhofer, Philipp Emanuel Bartko, Jutta K Bergler-Klein, Christian Nitsche · 2023 · Journal of Clinical Medicine
  97. Regional Differences in the Epidemiology of Heart Failure
    Jasper Tromp, Tiew‐Hwa Katherine Teng · 2024 · Korean Circulation Journal
  98. Contemporary treatment options in heart failure with preserved ejection fraction
    Alexander Peikert, Scott David Solomon · 2024 · European Heart Journal - Cardiovascular Imaging
  99. Prognostic Role of TAPSE to PASP Ratio in Outpatients with Left Ventricular Systolic Dysfunction
    Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio Maria Sammartino, Daniela Tomasoni, Riccardo Maria Inciardi, Carlo Lombardi, Marianna Adamo, Savina Nodari, Marco Metra · 2024 · ESC Heart Failure
  100. Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
    Davide Margonato, Simone Mazzetti, Renata De Maria, Marco Gorini, Massimo Iacoviello, Aldo Pietro Maggioni, Andrea Mortara · 2020 · Cardiac failure review